Question 1

Does MetLife Investment Management own IOVA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, MetLife Investment Management holds 232,151 shares of IOVA (Iovance Biotherapeutics), worth $965,748.

Question 2

How many shares of IOVA does MetLife Investment Management own?

Accepted Answer

As of its Q2 2026 13F, MetLife Investment Management holds 232,151 shares of IOVA (Iovance Biotherapeutics).

Question 3

What is MetLife Investment Management's IOVA position worth?

Accepted Answer

As of its Q2 2026 13F, MetLife Investment Management's IOVA position is worth $965,748.

Question 4

Is MetLife Investment Management buying or selling IOVA?

Accepted Answer

In Q2 2026, MetLife Investment Management increased its IOVA position by 47,752 shares (+25.9%).

Question 5

When did MetLife Investment Management first buy IOVA?

Accepted Answer

MetLife Investment Management already held IOVA in its Q1 2019 13F, the earliest on record, and has listed it in 23 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	232,151	+25.9%	$965,748	0.0%	$4.16	31
2026-Q1	Increased	184,399	+8.0%	$647,240	0.0%	$3.51	26
2025-Q4	Increased	170,782	+20.5%	$466,235	0.0%	$2.73	29
2025-Q3	Decreased	141,686	-6.2%	$307,459	0.0%	$2.17	0
2025-Q2	Decreased	150,974	-0.1%	$259,674	0.0%	$1.72	0
2025-Q1	Decreased	151,206	-8.8%	$503,516	0.0%	$3.33	0
2024-Q4	Increased	165,842	+13.3%	$1.2M	0.0%	$7.40	29
2024-Q3	Unchanged	146,416	0.0%	$1.4M	0.0%	$9.39	0